The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Singular Health Group's 9-Day RSI or its related term are showing as below:
ASX:SHG's 9-Day RSI is ranked worse than 53.29% of 700
companies
in the Healthcare Providers & Services industry
Industry Median: 51.335
vs ASX:SHG: 55.53
Singular Health Group (ASX:SHG) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Singular Health Group 9-Day RSI Related Terms
ASX:SHG vs VEEV, BTSG, TEM: 9-Day RSI Comparison
For the Health Information Services subindustry, Singular Health Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singular Health Group 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Singular Health Group's 9-Day RSI falls into.
Singular Health Group (ASX:SHG) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Health Group (ASX:SHG) has a 9-Day RSI of 55.53 as of Jul. 04, 2026. According to the industry distribution chart, Singular Health Group ranks #373 out of 700 companies in the Healthcare Providers & Services industry, placing it in the top 53.3%.
Is Singular Health Group's 9-Day RSI too high?
Singular Health Group's current 9-Day RSI is 55.53. The Healthcare Providers & Services industry median 9-Day RSI is 51.34. Singular Health Group's value of 55.53 is 8.2% above this industry median. Based on the distribution chart, Singular Health Group ranks #373 out of 700 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's 9-Day RSI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #373 out of 700 companies for 9-Day RSI. This places Singular Health Group in the lower half of its industry. The industry median 9-Day RSI is 51.34. Singular Health Group's value of 55.53 is 8.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 51.34, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singular Health Group's current 9-Day RSI of 55.53 is 8.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 51.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current 9-Day RSI is 55.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.21 — trading 90.9% above its estimated fair value. The current 9-Day RSI is 55.53 and 8.2% above the Healthcare Providers & Services industry median of 51.34. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current 9-Day RSI is 55.53 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.21 is trading 90.9% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
9-Day RSI: 55.53
GF Value™: A$0.11 vs. price of A$0.21 (90.9% above fair value)
Industry Position: 8.2% above the Healthcare Providers & Services median (#373 of 700)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score
Get the complete analysis for ASX:SHG
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 